Skip to main content

Committee questions NHS about healthcare data to assist older people

25 February 2020

The House of Lords Science and Technology Committee continues its inquiry into Ageing: Science, Technology and Healthy Living, by asking senior NHS officials about the use of data to plan health services for older people.

Purpose of sessions

The inquiry has heard about the importance of healthcare data for a range of purposes, including diagnosing illnesses, providing tailored care to patients, and conducting medical research. The Committee will ask the Head of NHSX and officials from NHS Digital how the NHS uses the vast amount of data that it gathers, in order to plan healthcare services. The Committee will also hear from  the National Data Guardian about the safeguards that govern the use of this patient data.

The Committee will then hear from academics about how they access data for research studies, and from representatives of the data industry about the benefits and challenges of combining datasets from the public and private sectors.


Tuesday 25 February in Committee Room 2, Palace of Westminster

At 10.20am

  • Dame Fiona Caldicott, National Data Guardian
  • Matthew Gould, CEO, NHSX
  • Chris Roebuck, Chief Statistician, NHS Digital
  • Dr Jem Rashbass, Executive Director of Master Registries and Data, NHS Digital

At around 11.25am

  • Charles Lowe, CEO, Digital Health and Care Alliance
  • Professor Julian Peto, Professor of Epidemiology, London School of Hygiene and Tropical Medicine
  • Dr Paola Zaninotto, Associate Professor in Medical Statistics, UCL
  • Dr Jeni Tennison, CEO, Open Data Institute

Possible questions

  • How is healthcare data currently used within the NHS, particularly for planning and designing services for an ageing population, and diagnosis and prevention of age-related diseases?
  • To what extent is healthcare data from the NHS shared outside the NHS, and what are the challenges associated with this?
  • How much integration is there between health data collected by private organisations (e.g. data from medical monitoring devices and from commercial wearables) and data collected in the NHS?
  • How much control do patients have over the use of their data?
  • Is there a gap between expectations of what data could achieve, and what is possible in reality?

Further information